S.B. Kaye
Impact in
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- PARP inhibition in cancer therapy
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 56
- Cancer Treatment and Pharmacology 18
- Lung Cancer Research Studies 11
- Drug Transport and Resistance Mechanisms 10
- PARP inhibition in cancer therapy 9
-
- Cancer therapeutics and mechanisms 21
- Co-authors
- R. M. Fox (2 shared papers)Alan S. Coates (2 shared papers)Anshoo Choudhary (1 shared paper)Martin H.N. Tattersall (2 shared papers)Suzanne Abraham (1 shared paper)T.R. Jeffry Evans (1 shared paper)Sally Stenning (3 shared papers)M.H. Cullen (2 shared papers)
- Journals
- British Journal of Cancer (28 papers)Journal of Clinical Oncology (25 papers)Annals of Oncology (22 papers)European Journal of Cancer (8 papers)Cancer Chemotherapy and Pharmacology (7 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
S.B. Kaye
140 papers receiving 6.4k citations
S.B. Kaye's Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 2.4k
- Reproductive Medicine 669
- Surgery 1.7k
- Cancer Research 375
- Molecular Biology 1.7k
Countries citing papers authored by S.B. Kaye
This map shows the geographic impact of S.B. Kaye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.B. Kaye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.B. Kaye more than expected).
Fields of papers citing papers by S.B. Kaye
This network shows the impact of papers produced by S.B. Kaye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.B. Kaye. The network helps show where S.B. Kaye may publish in the future.
Co-authors
The 25 scholars most cited alongside S.B. Kaye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | On the receiving end—patient perception of the side-effects of cancer chemotherapy Hit paper breakdown → | 1983 | 810 |
| 2 | 2001 | 372 | |
| 3 | 1998 | 349 | |
| 4 | 1992 | 294 | |
| 5 | 2006 | 256 | |
| 6 | 1998 | 224 | |
| 7 | 1996 | 223 | |
| 8 | 2001 | 191 | |
| 9 | 1999 | 184 | |
| 10 | 1991 | 164 | |
| 11 | 2016 | 127 | |
| 12 | 1983 | 127 | |
| 13 | 1986 | 126 | |
| 14 | 1993 | 123 | |
| 15 | 2010 | 117 | |
| 16 | 2000 | 113 | |
| 17 | 1993 | 107 | |
| 18 | 2016 | 106 | |
| 19 | 1996 | 103 | |
| 20 | 1985 | 103 |
About S.B. Kaye
S.B. Kaye is a scholar working on Oncology, Molecular Biology, Surgery, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 141 papers that have together received 6.7k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (33 papers), Cancer therapeutics and mechanisms (21 papers), Testicular diseases and treatments (20 papers), Cancer Treatment and Pharmacology (18 papers), Lung Cancer Research Studies (11 papers), Drug Transport and Resistance Mechanisms (10 papers), Neuroblastoma Research and Treatments (9 papers) and PARP inhibition in cancer therapy (9 papers). The work is most often cited by research in Oncology (2.4k citations), Reproductive Medicine (669 citations), Surgery (1.7k citations), Cancer Research (375 citations) and Molecular Biology (1.7k citations). S.B. Kaye has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include R. M. Fox, Alan S. Coates, Anshoo Choudhary, Martin H.N. Tattersall, Suzanne Abraham, T.R. Jeffry Evans, Sally Stenning, M.H. Cullen, M C Parkinson and A. Horwich. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.